Swine

We are at the forefront of developing a variety of vaccines that fight and contain swine-related diseases.

New manufacturing technology

We produce the world's only vaccine that can neutralize DNT from Bordetella bronchiseptica. We do so by developing the nontoxic variant of Pasteurella multocida DNT, the nontoxic variant of Bordetella bronchiseptica skin necrosis toxin, and Erysipelothrix rhusiopathiae surface protective antigen.

Our lineup for swine breeding

We manufacture and sell vaccines that prevent Japanese encephalitis, as well as porcine epidemic diarrhea (PED) and porcine atrophic rhinitis (AR) among nursing piglets via passive immunity, which can improve the results of breeding.

SUIMMUGENrART2/ER

SUIMMUGEN®ART2

Indications :

Prevention of swine erysipelas and swine atrophic rhinitis caused by Bordetella bronchiseptica and/or Pasteurella multocida

Antigen :

Non-toxic derivatives of Pasteurella multocida toxin (PMT) by E. coli in recombinant DNA technology
Non-toxic derivatives of Bordetella dermonecrotic toxin (DNT) by E. coli in recombinant DNA technology
The surface protective antigen (SpaA) of Erysipelothix rhusiopathiae (serotype 2) in E.coli recombinant DNA technology

Type :

Subunit

Adjuvant :

Aluminium
Hydroxide

Storage :

2-10°C

Dosage and Administration :

Gilts : Administer 2mL intramuscularly 5-6 weeks prior to farrowing. Repeat with a second 2mL dose 2 weeks prior to farrowing.
Sows : Administer 2 mL intramuscularly around 2 weeks prior to each subsequent farrowing.
Pigs (1 month and older) : Administer 1 mL intramuscularly. Recommended revaccination of pigs 2 to 3 weeks later.

SUIMMUGENrART2

Porcine Pasteurella Toxoid “KMB”

Indications :

Prevention of swine atrophic rhinitis caused by Bordetella bronchiseptica and/or Pasteurella multocida

Antigen :

Non-toxic derivatives of Pasteurella multocida toxin (PMT) by E. coli in recombinant DNA technology
Non-toxic derivatives of Bordetella dermonecrotic toxin (DNT) by E. coli in recombinant DNA technology

Type :

Subunit

Adjuvant :

Aluminium
Hydroxide

Storage :

2-10°C

Dosage and Administration :

Gilts : Administer 2mL intramuscularly 5-6 weeks prior to farrowing. Repeat with a second 2mL dose 2 weeks prior to farrowing.
Sows : Administer 2 mL intramuscularly around 2 weeks prior to each subsequent farrowing.
Pigs (1 month and older) : Administer 1 mL intramuscularly. Recommended revaccination of pigs 2 to 3 weeks later.

SUIMMUGENTGE/PED

SUIMMUGEN®TGE/PED

Indications :

Prevention of symptoms of porcine transmissible gastroenteritis and reduction of symptoms of porcine epidemic diarrhea in piglets through the transfer of antibodies in the colostrum and milk of vaccinated sow

Strain :

Transmissible gastroenteritis virus Ukiha
Porcine epidemic diarrhea virus 96-P4C6

Type :

Live

Adjuvant :

-

Storage :

2-10°C

Dosage and Administration :

Dissolve dried vaccine in accompanying dissolving solution, and administer the injection intramucularly at 2 ml each twice over 3 weeks to pregnant pigs. The second injection is to be administered around 2 weeks prior to delivery.

Veterinary Japanese Encephalitis TC Vaccine “KMB”

Veterinary Japanese Encephalitis TC Vaccine “KMB”

Indications :

Prevention of equine encephalitis and swine stillbirth caused by Japanese encephalitis virus

Strain :

Japanese encephalitis virus Beijing

Type :

inactivated

Adjuvant :

-

Storage :

2-10°C

Dosage and Administration :

[Prevention of porcine stillbirth caused by Japanese encephalitis virus]
Subcutaneously inject 2 ml of the attenuated Japanese encephalitis virus m strain in immune pigs after one month. Administer 2 ml subcutaneously to pigs with history of vaccination in the previous year.

Japanese Encephalitis-Porcine Parvovirus Infection Combined Live Vaccine “KMB”

Japanese Encephalitis-Porcine Parvovirus Infection Combined Live Vaccine “KMB”

Indications :

Prevention of Japanese encephalitis and porcine parvovirus infection. Prevention of swine stillbirth caused by Japanese encephalitis virus and porcine parvovirus virus.

Strain :

Japanese encephalitis virus m
Porcine parvovirus HT-/SK

Type :

Live

Adjuvant :

-

Storage :

2-10°C

Dosage and Administration :

Dissolve dried vaccine in accompanying dissolving solution, and administer 1 ml of the injection subcutaneously.

Porcine Parvovirus Infection Inactivated Vaccine “KMB”

Porcine Parvovirus Infection Inactivated Vaccine "KMB"

Indications :

Prevention of swine stillbirth caused by porcine parvovirus virus

Strain :

Porcine parvovirus 90HS-SK

Type :

Inactivated

Adjuvant :

-

Storage :

2-10°C

Dosage and Administration :

Inject subcutaneously at 2 ml twice over a 1- to 4-week period in sows.

Porcine Parvovirus Infection Live Vaccine “KMB”

Porcine Parvovirus Infection Live Vaccine "KMB"

Indications :

Prevention of porcine parvovirus infection

Strain :

Porcine parvovirus HT-/SK

Type :

Live

Adjuvant :

-

Storage :

2-10°C

Dosage and Administration :

Dissolve dried vaccine in accompanying dissolving solution, and administer 1 ml of the injection subcutaneously.

Swine Erysipelas Live Vaccine “KMB”

Porcine Pasteurella Toxoid “KMB”

Indications :

Prevention of swine erysipelas

Strain :

Acriflavine-resistant Erysipelothrix rhusiopathiae Koganei 65-0.15

Type :

Live

Adjuvant :

-

Storage :

2-10°C

Dosage and Administration :

Dissolve dried vaccine in accompanying dissolving solution. Administer 1mL of reconstituted vaccine to each pig via subcutaneous injection.